Pompano Beach, FL -- (SBWIRE) -- 02/06/2013 -- Csrnewsdaily.com, an investor research portal specializing in several sectors including biotech and healthcare and tech stocks on the U.S. market, issues news updates on the following Tuesday’s Top Gainers:-
Axcelis Technologies, Inc. (NASDAQ:ACLS) added 0.74% and is trading at $1.35. Axcelis Technologies, Inc. (Axcelis) designs, manufactures and services ion implantation, dry strip and other processing equipment used in the fabrication of semiconductor chips. The Company sells to semiconductor chip manufacturers worldwide.
Can ACLS Continue To Move Higher? Find Out Here
Merge Healthcare Inc. (NASDAQ:MRGE) is higher 0.78% and is trading at $2.58. Merge Healthcare Incorporated (Merge) develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians. Its solutions are designed to help solve some of the challenges in health information exchange, such as the incorporation of medical images and diagnostic information into broader health information technology (IT) applications and the interoperability of software solutions.
How Should Investors Trade MRGE Now? Find Out Here
Joe's Jeans Inc. (NASDAQ:JOEZ) is higher 1.59% and is trading at $1.28. Joe's Jeans Inc. (Joe's Jeans) is engaged in designing, developing and marketing its Joe's products, which include denim jeans, related casual wear and accessories. The Company sells its products to numerous retailers, which include department stores, specialty stores and distributors worldwide, and through its retail stores.
Can JOEZ Extend Rally? Find Out Here
Uni-Pixel Inc (NDA) (NASDAQ:UNXL) is higher 6.82% and is trading at $16.45. Uni-Pixel, Inc. (Uni-Pixel) is a production-stage company delivering its Performance Engineered Film (PEF) to the display, touch screen and flexible electronics markets. The Company has developed thin film high volume roll to roll or continuous flow manufacturing process.
How Should Investors React To UNXL Now? Find Out Here
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) added 1.45% and is trading at $2.76. Aeterna Zentaris Inc. is a late-stage drug development company specialized in oncology and endocrine therapy. The Company’s pipeline encompasses compounds at all stages of development, from drug discovery through to marketed products.
Can AEZS Extend Rally? Find Out Here
Csrnewsdaily.com has a finger on the pulse of many sectors including renewable energy, oil, pharma, mining, finance, and healthcare. Our in depth research and analysis of NASDAQ, OTCBB, Pink Sheets, and NYSE has yielded considerable gains for our subscribers.
Our to-the-minute reports and alerts coupled with breaking news, analysis, investment strategies, and FREE subscription email services contribute to our role as one of the leading investor relations marketing firms.
The assembled information disseminated by Csrnewsdaily.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Csrnewsdaily.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)